On the recordApril 17, 2013
Do you feel like the FDA has the resources necessary to stay on top of all the changes that are coming with nano materials and nanotechnology?
Source
congress.govEditor's note · Context
Senator Pryor questions FDA's capacity to manage emerging nanotechnology.
Share
More from Mark Pryor
Dec 11, 2014
I ask unanimous consent that the bill be read a third time and passed and the motion to reconsider be considered made and laid upon the table with no intervening action or debate. The PRESIDING OFFICER. Without objection, it is so ordered…
Dec 16, 2014
I ask unanimous consent that the Judiciary Committee be discharged from further consideration of S. Res. 226, and the Senate proceed to its consideration. The PRESIDING OFFICER. Without objection, it is so ordered. The clerk will report…
Dec 16, 2014
I ask unanimous consent that the amendment to the resolution that is at the desk be agreed to; the resolution, as amended, be agreed to; the amendment to the preamble be agreed to; the preamble, as amended, be agreed to; and the motions to…
Dec 11, 2014
I ask unanimous consent that the bill be read a third time and passed, and the motion to reconsider be considered made and laid upon the table. The PRESIDING OFFICER. Without objection, it is so ordered. The bill (H.R. 4771) was ordered to…
Other voices in this conversation
